Retatrutide 40mg Injection Pen Kit
The Retatrutide 40mg Injection Pen Kit from Synedica is an advanced multi-receptor agonist engineered for laboratory research applications. Formulated to high analytical standards, this product combines high-purity Retatrutide compound with a pre-calibrated delivery device to streamline precise analytical workflows.
Technical Specifications of the Synedica Retatrutide 40mg Pen
-
Compound Name: Retatrutide (Triple GLP-1 / GIP / Glucagon Agonist)
-
Total Active Concentration: 40mg active research compound per unit
-
Delivery System: Integrated pre-measured synedica retatrutide 40mg pen kit format
-
Purity Rating: ≥99.0% (Verified via High-Performance Liquid Chromatography)
-
Form Factor: Lyophilized formulation with specialized administration pen housing
-
Storage Protocols: Store at -20°C upon arrival; stable at ambient room temperature during short-term transit
Why Choose the Official Synedica Retatrutide 40mg Format?
When evaluating triple-agonist peptide research, precision baseline data depends directly on compound purity and exact volume handling.
HPLC Verified Batch Traceability
Every batch of synedica retatrutide 40mg undergoes rigorous third-party testing—including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry—to verify exact chemical identity and rule out impurities.
Streamlined Analytical Handling
The pre-calibrated synedica retatrutide 40mg pen format reduces manual reconstitution steps and minimizes dosage margin-of-error during extended longitudinal laboratory studies.
Frequently Asked Questions
How is the Synedica Retatrutide 40mg Pen delivered?
All orders are packaged securely and dispatched directly within the UK to ensure temperature stability and complete physical protection during transit.
Where can I verify the Certificate of Analysis (COA)?
Each synedica retatrutide 40mg unit features a lot-specific batch number that corresponds directly to the downloadable third-party lab documentation in our online COA directory.
Notice: All Synedica products—including the synedica retatrutide 40mg pen kit—are sold strictly for in vitro laboratory research, analytical studies, and scientific development. Products are not intended for human or animal consumption, medical treatment, or therapeutic use.







